SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-23-001850
Filing Date
2023-01-19
Accepted
2023-01-19 12:13:57
Documents
18

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 2733489
2 ex23-1.htm EX-23.1 6939
3 ex107.htm EX-FILING FEES 22211
4 ex23-1_001.jpg GRAPHIC 2105
5 ex23-1_002.jpg GRAPHIC 1561
6 formf-1a_001.jpg GRAPHIC 9359
7 formf-1a_002.jpg GRAPHIC 76342
8 formf-1a_014.jpg GRAPHIC 23287
9 formf-1a_015.jpg GRAPHIC 23287
10 formf-1a_005.jpg GRAPHIC 15729
11 formf-1a_006.jpg GRAPHIC 25106
12 formf-1a_007.jpg GRAPHIC 18514
13 formf-1a_008.jpg GRAPHIC 31534
14 formf-1a_009.jpg GRAPHIC 16605
15 formf-1a_010.jpg GRAPHIC 19347
16 formf-1a_011.jpg GRAPHIC 31331
17 formf-1a_012.jpg GRAPHIC 32897
18 formf-1a_013.jpg GRAPHIC 9361
  Complete submission text file 0001493152-23-001850.txt   3228543
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-268675 | Film No.: 23536648
SIC: 2836 Biological Products, (No Diagnostic Substances)